Preventing a broken heart: Research aims to reduce scarring from heart attacks

December 14, 2008

A heart damaged by heart attack is usually broken, at least partially, for good. The injury causes excessive scar tissue to form, and this plays a role in permanently keeping heart muscle from working at full capacity.

Now researchers have identified a key molecule involved in controlling excessive scar tissue formation in mice following a heart attack. When they stopped the scarring from occurring, the scientists found that the animals' heart function greatly improved following the injury.

The study, by scientists at the University of Wisconsin-Madison and Cornell University, appears in Nature Cell Biology online Dec. 14, 2008.

The findings offer heartening news for the millions who have heart attacks each year and suffer from the resulting poor heart function. The study raises the hope that the outlook for people with this major disability might be markedly improved.

The scientists studied a protein, sFRP2, which they unexpectedly found to be involved in the formation of collagen, the main component of scar tissue.

"With many injuries and diseases, large amounts of collagen are formed and deposited in tissues, leading to scarring and a condition called fibrosis," explains co-author Daniel S. Greenspan, professor of pathology and laboratory medicine at the UW School of Medicine and Public Health. "Fibrosis can seriously affect the functioning of heart, lung, liver and other tissues."

Greenspan, an expert on collagen, joined with Thomas Sato of Weill Cornell Medical College to study mice that don't produce sFRP2 to understand how the protein works. When the scientists restricted blood flow to the animals' hearts, mimicking a heart attack, they found that scarring was significantly reduced in these sFRP2-free animals.

"Importantly, we found that when we reduced the level of fibrosis, heart function significantly improved in the mice," says Greenspan, also a professor of pharmacology at UW-Madison.

Identifying agents that specifically target sFRP2 and halt its activity will be a promising approach to controlling heart attack-induced scarring and impaired heart function, says Greenspan, and his lab has begun the search. The UW scientists also hope to study how sFRP2 and other proteins that enhance collagen formation may interact.

The protein may also be important in treating other diseases resulting in severe fibrosis, adds Greenspan, including liver cirrhosis and interstitial lung disease.

Source: University of Wisconsin-Madison

Related Stories

Recommended for you

Study reveals connection between microbiome and autoimmune disorders

October 23, 2017
Many people associate the word "bacteria" with something dirty and disgusting. Dr. Pere Santamaria disagrees. Called the microbiome, the bacteria in our bodies have all kinds of positive effects on our health, Santamaria ...

Engineered protein treatment found to reduce obesity in mice, rats and primates

October 19, 2017
(Medical Xpress)—A team of researchers with pharmaceutical company Amgen Inc. report that an engineered version of a protein naturally found in the body caused test mice, rats and cynomolgus monkeys to lose weight. In their ...

New procedure enables cultivation of human brain sections in the petri dish

October 19, 2017
Researchers at the University of Tübingen have become the first to keep human brain tissue alive outside the body for several weeks. The researchers, headed by Dr. Niklas Schwarz, Dr. Henner Koch and Dr. Thomas Wuttke at ...

Cancer drug found to offer promising results in treating sepsis in test mice

October 19, 2017
(Medical Xpress)—A combined team of researchers from China and the U.S. has found that a drug commonly used to treat lung cancer in humans offers a degree of protection against sepsis in test mice. In their paper published ...

Tracing cell death pathway points to drug targets for brain damage, kidney injury, asthma

October 19, 2017
University of Pittsburgh scientists are unlocking the complexities of a recently discovered cell death process that plays a key role in health and disease, and new findings link their discovery to asthma, kidney injury and ...

Study reveals key molecular link in major cell growth pathway

October 19, 2017
A team of scientists led by Whitehead Institute has uncovered a surprising molecular link that connects how cells regulate growth with how they sense and make available the nutrients required for growth. Their work, which ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.